Eride Quarta

Parma, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Lpb. plantarum inhalation powders for the reduction of lung inflammation and S. aureus growth control in non-CF bronchiectasis.

Lpb. plantarum inhalation powders for the reduction of lung inflammation and S. aureus growth control in non-CF bronchiectasis.

Journal: Expert opinion on drug delivery

Published: August 30, 2026

Inhaled product dissolution as a predictive tool of drug bioavailability: a p38 MAPK inhibitor case study using Respicell® dissolution apparatus.

Inhaled product dissolution as a predictive tool of drug bioavailability: a p38 MAPK inhibitor case study using Respicell® dissolution apparatus.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: June 19, 2026

CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases.

CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases.

Journal: Pharmaceutics

Published: April 08, 2026

Site-Specific Microparticle Inhalation Therapy: A New Approach to Nasopharyngeal Symptoms.

Site-Specific Microparticle Inhalation Therapy: A New Approach to Nasopharyngeal Symptoms.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 01, 2025

Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways.

Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways.

Journal: Drug delivery and translational research

Published: June 28, 2025

Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections.

Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections.

Journal: Antibiotics (Basel, Switzerland)

Published: January 03, 2025

Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects.

Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects.

Journal: International journal of pharmaceutics

Published: October 18, 2024

The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract.

The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract.

Journal: Expert opinion on drug delivery

Published: July 23, 2024

Novel Dry Hyaluronic Acid-Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis.

Novel Dry Hyaluronic Acid-Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis.

Journal: Pharmaceutics

Published: February 06, 2024

Nasal delivery as a strategy for the prevention and treatment of COVID-19.

Nasal delivery as a strategy for the prevention and treatment of COVID-19.

Journal: Expert opinion on drug delivery

Published: September 27, 2023

Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure.

Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure.

Journal: Journal of the American College of Cardiology

Published: June 23, 2023

Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa.

Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa.

Journal: International journal of antimicrobial agents

Published: May 12, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026